Aterojenik dislipidemiye yeni bir yaklaşim

Translated title of the contribution: Commentary: A new approach to atherogenic dyslipidemia

Research output: Contribution to journalReview articlepeer-review


It seems clear that atherogenic dyslipidemia represents and imbalance in cholesterol transport, resulting in more cholesterol being delivered to the blood vessel wall and less being removed. Statin therapy can decrease diabetic patients' coronary event risk to a level comparable to that of untreated persons with-out diabetes. Combining treatments aimed at raising HDL-C with use of a statin is necessary to achieve a favorable outcome for our insulin-resistant patients with atherogenic dyslipidemia.

Translated title of the contributionCommentary: A new approach to atherogenic dyslipidemia
Original languageTurkish
Pages (from-to)22-25
Number of pages4
Issue number4
StatePublished - Apr 1 2006

ASJC Scopus subject areas

  • Medicine(all)


Dive into the research topics of 'Commentary: A new approach to atherogenic dyslipidemia'. Together they form a unique fingerprint.

Cite this